These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 36114073)

  • 21. A Rare Case of Pembrolizumab-Induced Uveitis in a Patient with Metastatic Melanoma.
    Hanna KS
    Pharmacotherapy; 2016 Nov; 36(11):e183-e188. PubMed ID: 27716999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pembrolizumab combined with stereotactic body radiotherapy in a patient with human immunodeficiency virus and advanced non-small cell lung cancer: a case report.
    Li D; He C; Xia Y; Du Y; Zhang J
    J Med Case Rep; 2018 Apr; 12(1):104. PubMed ID: 29681240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ulcerative enteritis. How the extension of ulcerative colitis to small bowel may jeopardize postcolectomy course: a case report and literature review.
    Gonella F; Massucco P; Daperno M; Mineccia M; Perotti S; Rocca R; Ferrero A
    Eur J Gastroenterol Hepatol; 2021 Apr; 33(4):589-594. PubMed ID: 33657604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Behcet's-like syndrome following pembrolizumab: An immune-related adverse event associated with programmed death receptor-1 inhibitor therapy.
    Thomas S; Bae C; Joy-Ann T; Traverse W
    J Oncol Pharm Pract; 2020 Jun; 26(4):995-999. PubMed ID: 31575354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A Case of Immune-Related Adverse Events Affecting the Lungs, Skin, and Pituitary Gland during Pembrolizumab Treatment].
    Ito R; Tatsuoka H; Hirata T; Kimura S; Sakamoto Y; Kashiwagi T; Hori J; Miyata K; Kishi M; Iwai M
    Gan To Kagaku Ryoho; 2021 Oct; 48(10):1265-1267. PubMed ID: 34657060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Small bowel hemorrhage from check point inhibitor enteritis: a case report.
    Young K; Lin E; Chen E; Brinkerhoff B; Scott G; Yu J
    BMC Gastroenterol; 2021 Sep; 21(1):345. PubMed ID: 34493214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ulcerative colitis associated enteritis: is ulcerative colitis always confined to the colon?
    Rubenstein J; Sherif A; Appelman H; Chey WD
    J Clin Gastroenterol; 2004 Jan; 38(1):46-51. PubMed ID: 14679327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucagon-like peptide 2: a new treatment for chemotherapy-induced enteritis.
    Tavakkolizadeh A; Shen R; Abraham P; Kormi N; Seifert P; Edelman ER; Jacobs DO; Zinner MJ; Ashley SW; Whang EE
    J Surg Res; 2000 Jun; 91(1):77-82. PubMed ID: 10816354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vanishing bile duct syndrome following pembrolizumab infusion: case report and review of the literature.
    Gemelli M; Carbone M; Abbate MI; Mancin M; Zucchini N; Colonese F; Invernizzi P; Bidoli P; Cortinovis D
    Immunotherapy; 2022 Mar; 14(4):175-181. PubMed ID: 34873918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pembrolizumab-induced interstitial lung disease following thoracic surgery in a patient with non-small cell lung cancer.
    Fujita T; Hayama N; Kuroki T; Shiraishi Y; Amano H; Nakamura M; Hirano S; Aramaki N; Ichinose S; Shimizu S; Tabeta H; Nakamura S
    Thorac Cancer; 2019 Nov; 10(11):2179-2182. PubMed ID: 31512401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pembrolizumab-induced myasthenia gravis: A fatal case report.
    March KL; Samarin MJ; Sodhi A; Owens RE
    J Oncol Pharm Pract; 2018 Mar; 24(2):146-149. PubMed ID: 28147928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pembrolizumab-related cholangitis with multiple fatal liver abscesses after endoscopic biliary drainage: a case report and review of the literature.
    Hori H; Fujita K; Nishio A; Nishijima M; Inaba M; Anami T; Matsui S; Kitamura Y; Matsuoka R; Watanabe A
    Clin J Gastroenterol; 2022 Apr; 15(2):475-479. PubMed ID: 35072901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A case of ulcerative colitis-related postoperative enteritis treated with granulocyte and monocyte apheresis.
    Adachi K; Sugiyama T; Yamaguchi Y; Tamura Y; Izawa S; Ebi M; Funaki Y; Ogasawara N; Sasaki M; Kasugai K
    Clin J Gastroenterol; 2023 Feb; 16(1):43-47. PubMed ID: 36214972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Compromise or not? A case report of successful treatment of pembrolizumab-induced hepatitis in a patient with non-small cell lung cancer with low-dose methylprednisolone and bicyclol.
    Liu Y; Zhang J; Yin Z; Zhu X; Xue L; Cao B
    Thorac Cancer; 2020 Jul; 11(7):2023-2030. PubMed ID: 32379397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pembrolizumab-Induced Seronegative Arthritis and Fasciitis in a Patient with Lung Adenocarcinoma.
    Kobak S
    Curr Drug Saf; 2019; 14(3):225-229. PubMed ID: 31132977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pseudomonas aeruginosa as a cause of infectious diarrhea successfully treated with oral ciprofloxacin.
    Porco FV; Visconte EB
    Ann Pharmacother; 1995 Nov; 29(11):1122-3. PubMed ID: 8573957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ulcerative colitis-related postoperative enteritis treated with anti-tumor necrosis factor therapy: two case reports and a literature review.
    Shimoda F; Kuroha M; Chiba H; Abe I; Yano K; Inomata Y; Takahashi T; Shimoyama Y; Moroi R; Shiga H; Kakuta Y; Fujishima F; Masamune A
    Clin J Gastroenterol; 2021 Oct; 14(5):1396-1403. PubMed ID: 34302278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Haemorrhagic shock secondary to a diffuse ulcerative enteritis after Ipilimumab and Nivolumab treatment for metastatic melanoma: a case report.
    Trystram N; Laly P; Bertheau P; Baroudjian B; Aparicio T; Gornet JM
    Ann Palliat Med; 2022 Feb; 11(2):837-842. PubMed ID: 34118829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A patient with advanced lung squamous cell carcinoma who failed to benefit from albumin bound paclitaxel plus pembrolizumab achieved partial response with second-line treatment of docetaxel plus pembrolizumab: a case report.
    Zhang F; Xu Y; Guo S; Li S; Ma K; Wang J; Wei S
    Ann Palliat Med; 2022 Sep; 11(9):3020-3027. PubMed ID: 36217630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.